Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 25, 2024
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
David Hoang Initiated (ABOS) at Strong Buy and Held Target at $7 on, Jul 25th, 2024
David Hoang of Citigroup, Initiated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $7 on, Jul 25th, 2024.
David has made no other calls on ABOS in the last 4 months.
There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Wednesday, May 15th, 2024
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $14 on, Sunday, March 31st, 2024
